Pain Management Market: By Type (Pain Managements Drug (NSAIDS, Anesthetics, Antidepressants, Opioids, Anesthetics, Antihistamine Agents, Others), Pain Management Devices (Neurostimulation devices, Ablation Devices, Analgesic Infusion Pumps, Others)), By Condition ( Cancer Pain, Musculoskeletal Pain, Neuropathic Pain, Migraine & Facial Pain, Others), By Distribution Channel ( Hospitals, Clinics, Others), By Seviority (Chronic Pain, Acute Pain) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Pain Management Market size was valued at USD 38.8 billion in 2022 and is expected to reach USD 64.9 billion by 2028, at a significant CAGR of 7.6% from 2023-2029. Pain management caused by the intense damage of the tissue or any other illness. Pain may be the result of injury or different diseases such as diabetic neuropathy, arthritis, osteoarthritis, sclerosis, cancer, fibromyalgia or others. The management of the pain based on the severity and type of the pain. Pain can be classified into two types based on intensity, acute and chronic. Acute pain is sudden onset of the pain whre as chronic pain is persistent, usually due to ageing. There were many pain management solutions available in the market in form of drugs, devices and therapies. The global healthcare system has been influenced by the COVID-19 epidemic. The health officials are working to stop the spread of the coronavirus by enforcing lockdown rules, and most elective and non-urgent surgeries have been postponed around the world. As per the research article published in the Indian Journal of Anaesthesia 2020, COVID-19 has a negative impact on pain clinics, including interventional pain management procedures. The Indian Society of Anaesthesiologists also released recommendations on anaesthesia and intensive care techniques.

Global Pain Management Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.6%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
Pain Management Market

Huge number of factors such as advancements in the pain management techniques such as Neurostimulation devices, increase in ageing population, and established reimbursement scenario are projected to boost the market growth over the forecast period. In addition, high rates of trauma conditions, incidence of the chronic diseases such as arthritis, and cancer expected to bolster the market growth over the forecast period. However, low awareness among the patient pool regarding the availability of low invasive pain management techniques and alternative treatment methods are expected to hamper the market growth over the forecast period.

Key Features of the Reports

  • In August 2017, Ajanta Pharma has launched eletriptan hydro bromide tablets for treatment of headaches in US market.

Global Pain Management Market Segmentation

By Type
  • Pain Managements Drug
    • NSAIDS
    • Anesthetics
    • Antidepressants
    • Opioids
    • Anesthetics
    • Antihistamine Agents
    • Others
  • Pain Management Devices
    • Neurostimulation devices
    • Ablation Devices
    • Analgesic Infusion Pumps
  • Others
By Condition
  • Cancer Pain
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Migraine & Facial Pain
  • Others
By Distribution Channel
  • Hospitals
  • Clinics
  • Others
By Seveority
  • Chronic Pain
  • Acute Pain
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Frequently Asked Questions

The key segments covered in the Pain Management Market are technology, components, application, and end-users.

The Pain Management Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Pain Management Market key players are Medtronic Plc (Ireland), DJO Global Inc. (U.S.), GlaxoSmithKline Plc (U.K.), Johnson and Johnson (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel)

1.Executive Summary
2.Global Pain Management Market Introduction 
2.1.Global Pain Management Market  - Taxonomy
2.2.Global Pain Management Market  - Definitions
2.2.1.Type
2.2.2.Condition
2.2.3.Distribution Channel
2.2.4.Seveority
2.2.5.Region
3.Global Pain Management Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Pain Management Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Pain Management Market  By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Pain Managements Drug
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Pain Management Devices
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Pain Management Market  By Condition, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Cancer Pain
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Musculoskeletal Pain
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Neuropathic Pain
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Migraine & Facial Pain
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Pain Management Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Pain Management Market  By Seveority, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Chronic Pain
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Acute Pain
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9.Global Pain Management Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Pain Managements Drug
10.1.2.Pain Management Devices
10.1.3.Others
10.2.  Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cancer Pain
10.2.2.Musculoskeletal Pain
10.2.3.Neuropathic Pain
10.2.4.Migraine & Facial Pain
10.2.5.Others
10.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Others
10.4.  Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Chronic Pain
10.4.2.Acute Pain
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Pain Managements Drug
11.1.2.Pain Management Devices
11.1.3.Others
11.2.  Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cancer Pain
11.2.2.Musculoskeletal Pain
11.2.3.Neuropathic Pain
11.2.4.Migraine & Facial Pain
11.2.5.Others
11.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Others
11.4.  Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Chronic Pain
11.4.2.Acute Pain
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Pain Managements Drug
12.1.2.Pain Management Devices
12.1.3.Others
12.2.  Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cancer Pain
12.2.2.Musculoskeletal Pain
12.2.3.Neuropathic Pain
12.2.4.Migraine & Facial Pain
12.2.5.Others
12.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Others
12.4.  Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Chronic Pain
12.4.2.Acute Pain
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Pain Managements Drug
13.1.2.Pain Management Devices
13.1.3.Others
13.2.  Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cancer Pain
13.2.2.Musculoskeletal Pain
13.2.3.Neuropathic Pain
13.2.4.Migraine & Facial Pain
13.2.5.Others
13.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Others
13.4.  Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Chronic Pain
13.4.2.Acute Pain
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Pain Managements Drug
14.1.2.Pain Management Devices
14.1.3.Others
14.2.  Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Cancer Pain
14.2.2.Musculoskeletal Pain
14.2.3.Neuropathic Pain
14.2.4.Migraine & Facial Pain
14.2.5.Others
14.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospitals
14.3.2.Clinics
14.3.3.Others
14.4.  Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Chronic Pain
14.4.2.Acute Pain
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Medtronic Plc (Ireland)
15.2.2.DJO Global Inc. (U.S.)
15.2.3.GlaxoSmithKline Plc (U.K.)
15.2.4.Johnson and Johnson (U.S.)
15.2.5.Novartis AG (Switzerland)
15.2.6.Pfizer Inc. (U.S.)
15.2.7.Teva Pharmaceutical Industries Ltd. (Israel)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Medtronic Plc (Ireland)
  • DJO Global Inc. (U.S.)
  • GlaxoSmithKline Plc (U.K.)
  • Johnson and Johnson (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)

Adjacent Markets